TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997
TCL Archive Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described July 25, 1975